Labcorp will perform antibody test at no charge to accelerate COVID-19 blood plasma donation

BURLINGTON, N.C. --(BUSINESS WIRE)--Aug. 11, 2020-- Labcorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced details of a no charge antibody testing program in response to federal health authorities’ request to increase donations of COVID-19 blood plasma. Plasma with COVID-19 antibodies may be helpful when treating patients with an active COVID-19 infection and is being evaluated as a possible treatment.

Media Statement: Result timeframes

Media Statement: LabCorp is proud to be part of The Fight Is In Us Coalition to increase donations of blood plasma with COVID-19 antibodies

Labcorp working with public health authorities on no-charge antibody test program to accelerate COVID-19 blood plasma donation

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 30, 2020-- Labcorp (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced plans to create a program to offer total antibody testing at no charge through the patient’s doctor in support of increased blood plasma donations for use as a possible COVID-19 treatment.